Format

Send to

Choose Destination
Semin Ophthalmol. 2007 Jul-Sep;22(3):151-3.

Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome.

Author information

1
Department of Ophthalmology, University of California, Davis, Sacramento, CA, USA.

Abstract

Docetaxel (Taxotere) is an anticancer agent used to treat a wide range of malignancies including breast, lung, and prostate cancer. In this report, we describe a patient with bilateral vision loss due to cystoid macular edema (CME) associated with docetaxel therapy. This report documents for the first time the optical coherence tomography (OCT) findings of CME despite the lack of leakage with flourescein angiography and its association with the Fluid Retention Syndrome (FRS). Successful management of CME with oral acetazolamide is also discussed.

PMID:
17763235
DOI:
10.1080/08820530701457373
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center